The population pressure, the growing prevalence of diseases, and the increasing number of surgeries and chronic and traumatic wounds make the global medical tapes and bandages market one that is significantly rising.

This segment is expected to reach US$ 8.59 billion by 2026 globally, US$ 850.1 million of which in India, as reported on the “Medical Tapes and Bandages Market – Global Forecast 2026” by MarketsandMarkets.

H.B. Fuller, one of the world’s leading adhesives suppliers, announces the launch of Swiftmelt 1515-I, its first bio-compatible product compliant in India, Middle East, and Africa (IMEA).

Swiftmelt 1515-I meets performance requirements and secures skin attachment.

The product is for microporous medical tape applications to be used in stick-to-skin under unique climatic conditions, such as the high temperatures and humidity in the Indian sub-continent.

Swiftmelt 1515-I delivers effective high tack, secure and quick bonding, under high temperature and with shear resistance. The product, which shows high performance, balancing adhesion and ease of removal, was thoroughly tested and certified by ISO 10993-5 for cytotoxicity. Since it is not toxic to human cells, the adhesive can effectively be used in medical applications in hospitals and home care in stick-to-skin situations.

“This is a breakthrough from our H.B. Fuller’s R&D team in India, which has developed this new technology in our lab in Pune, in response to the IMEA market specifics to support advanced stick-to-skin product compliant for medical use – such as nonwoven surgical,” commented Manish Dwivedi, flexible materials, business manager for India, H.B. Fuller.